RBC Capital Reiterates Sector Perform on Gilead Sciences, Maintains $88 Price Target
Portfolio Pulse from richadhand@benzinga.com
RBC Capital analyst Brian Abrahams reiterated a Sector Perform rating on Gilead Sciences (NASDAQ:GILD) and maintained an $88 price target.
June 23, 2023 | 1:54 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
RBC Capital analyst Brian Abrahams reiterated a Sector Perform rating on Gilead Sciences and maintained an $88 price target.
The news is directly related to Gilead Sciences as RBC Capital analyst Brian Abrahams reiterated a Sector Perform rating and maintained an $88 price target. This rating suggests that the stock is expected to perform in line with the market, which is a neutral outlook for the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100